We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLCA
551
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.01M | 0.02% |
88,456
+62,218
| +237% | +$1.15M |
|
552
Bank of America
BAC
$435B
| $2.01M | 0.02% |
+148,367
| New | +$2M |
|
|
WCN
553
Waste Connections
WCN
$42.8B
| $1.98M | 0.02% |
+46,058
| New | +$1.86M |
|
554
Cencora
COR
$60.3B
| $1.98M | 0.02% |
22,847
-29,960
| -57% | -$2.67M |
|
555
Texas Instruments
TXN
$255B
| $1.97M | 0.02% |
34,264
-47,618
| -58% | -$2.53M |
|
556
Bio-Techne
TECH
$11.2B
| $1.97M | 0.02% |
83,184
+70,908
| +578% | +$1.56M |
|
|
USCR
557
DELISTED
U S Concrete, Inc.
USCR
| $1.96M | 0.02% |
+32,965
| New | +$1.68M |
|
|
AXLL
558
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $1.96M | 0.02% |
+89,827
| New | +$1.58M |
|
|
TFCF
559
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $1.96M | 0.02% |
69,434
-659,934
| -90% | -$17.7M |
|
560
Royal Caribbean
RCL
$78.7B
| $1.95M | 0.02% |
+23,787
| New | +$1.86M |
|
561
Healthpeak Properties
DOC
$15.4B
| $1.95M | 0.02% |
+65,542
| New | +$1.97M |
|
562
MacroGenics
MGNX
$235M
| $1.94M | 0.02% |
103,458
+9,749
| +10% | +$186K |
|
563
Atlantic Union Bankshares
AUB
$5.99B
| $1.93M | 0.02% |
+78,393
| New | +$1.81M |
|
564
Coeur Mining
CDE
$15.6B
| $1.92M | 0.02% |
341,216
+243,742
| +250% | +$844K |
|
|
EXTN
565
DELISTED
Exterran Corporation
EXTN
| $1.92M | 0.02% |
123,979
+66,192
| +115% | +$1M |
|
566
eBay
EBAY
$48.6B
| $1.91M | 0.02% |
+79,894
| New | +$1.94M |
|
|
GG
567
DELISTED
Goldcorp Inc
GG
| $1.9M | 0.02% |
+117,160
| New | +$1.63M |
|
|
SAGE
568
DELISTED
Sage Therapeutics
SAGE
| $1.9M | 0.02% |
59,222
+27,148
| +85% | +$956K |
|
569
Acuity Brands
AYI
$9.88B
| $1.89M | 0.02% |
8,653
-71,395
| -89% | -$14.7M |
|
570
AbbVie
ABBV
$458B
| $1.88M | 0.02% |
32,969
-10,458
| -24% | -$583K |
|
|
VLP
571
DELISTED
Valero Energy Partners LP
VLP
| $1.88M | 0.02% |
+39,608
| New | +$1.84M |
|
572
Range Resources
RRC
$9.11B
| $1.88M | 0.02% |
57,919
-41,428
| -42% | -$1.15M |
|
573
UGI
UGI
$8B
| $1.85M | 0.02% |
+45,859
| New | +$1.66M |
|
|
RICE
574
DELISTED
Rice Energy Inc.
RICE
| $1.84M | 0.02% |
131,895
-640,149
| -83% | -$6.66M |
|
|
TRVN
575
DELISTED
Trevena, Inc.
TRVN
| $1.83M | 0.02% |
354
+60
| +20% | +$302K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.